Shariah compliance overview
HalalAddex Therapeutics Ltd (ADXN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Addex Therapeutics Ltd
Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders.
Addex Therapeutics Ltd (ADXN) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.00% (limit 5%), interest-bearing debt is 0.00% (limit 30%) and interest-bearing securities and assets are 26.38% (limit 30%).
- Business Activity
- 0.00%Limit 5%Pass
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 26.38%Limit 30%Pass
- Dividend purification
- 0.00%Share of dividends to give to charityPurification calculator
Last updated: Oct 23, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Addex Therapeutics Ltd (ADXN). Current Akinda screening label: Halal.
